Asiatic Laboratories Limited (DSE: ASIATICLAB)

Asiatic Laboratories Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Jun 30, 2021	Jun 30, 2021	Jun 30, 2020
Net Income	320.52	320.52	242.45
Depreciation & Amortization	104.9	104.9	94.28
Other Amortization	0.5	0.5	0.21
Other Operating Activities	44.2	44.2	93.5
Change in Accounts Receivable	-15.91	-15.91	-21.63
Change in Inventory	-32.58	-32.58	-45.81
Change in Accounts Payable	-4.86	-4.86	-10.58
Change in Other Net Operating Assets	15.23	15.23	-7.82
Operating Cash Flow	432.01	432.01	344.61
Operating Cash Flow Growth	-	25.36%	-
Capital Expenditures	-375.1	-375.1	-185.33
Sale (Purchase) of Intangibles	-	-	-3.5
Investing Cash Flow	-375.1	-375.1	-188.83
Short-Term Debt Repaid	-0.31	-0.31	-63.51
Long-Term Debt Repaid	-14.83	-14.83	-38.22
Total Debt Repaid	-15.14	-15.14	-101.73
Net Debt Issued (Repaid)	-15.14	-15.14	-101.73
Other Financing Activities	-44.32	-44.32	-51.74
Financing Cash Flow	-59.47	-59.47	-153.47
Foreign Exchange Rate Adjustments	0.27	0.27	0.17
Net Cash Flow	-2.28	-2.28	2.48
Free Cash Flow	56.91	56.91	159.27
Free Cash Flow Growth	-	-64.27%	-
Free Cash Flow Margin	3.92%	3.92%	12.01%
Free Cash Flow Per Share	0.65	0.65	1.81
Cash Interest Paid	43.92	43.92	51.38
Cash Income Tax Paid	44.1	44.1	54.85
Levered Free Cash Flow	-55.04	-55.04	-
Unlevered Free Cash Flow	-27.59	-27.59	-
Change in Net Working Capital	17.58	17.58	-

Source: S&P Capital IQ. Standard template. Financial Sources.